Atlas Trials

Impact of Blastocyst Morphological Development and Blastocoele Re-expansion on Pregnancy Outcome After Using REKOVELLE®

Clinical trial NCT03697031 · TERMINATED

Trial details

NCT number
NCT03697031
Sponsor
Ferring Pharmaceuticals
Status
TERMINATED
Study type
OBSERVATIONAL
Controlled Ovarian Stimulation
Start date
2018-09-01
Primary completion
2020-12-31
Enrollment
362

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.